Zobrazeno 101 - 110
of 167
pro vyhledávání: '"Pauline, Funchain"'
Publikováno v:
Journal of Clinical Oncology. 38:3144-3144
3144 Background: Radiotherapy (RT) potentiates immune-mediated responses against tumor antigens, an effect that is enhanced by checkpoint inhibitors (CPIs) and may hold therapeutic promise. However, the mechanisms underlying this abscopal effect can
Thromboembolism (TE) in patients (pts) with bladder cancer treated with checkpoint inhibitors (CPIs)
Autor:
Iris Yeong Fung Sheng, Shilpa Gupta, Pauline Funchain, Chandana A. Reddy, Moshe Chaim Ornstein, Timothy D. Gilligan, Dana E. Angelini, Joseph Sleiman, Alok A. Khorana, Tamara A. Sussman
Publikováno v:
Journal of Clinical Oncology. 38:5042-5042
5042 Background: Most pts with bladder cancer will be treated with immunotherapy. There is concern for increased TE risk with CPIs in this already high risk population. We present the first analysis of the incidence and outcomes of venous (VTE) and a
Publikováno v:
BMJ Case Rep
As immune checkpoint inhibitors (ICIs) are increasingly used, clinicians are more frequently encountering the side effects of these therapies. ICIs have been implicated in numerous adverse effects against healthy tissues. We present a case of a patie
Autor:
Tapas Ranjan Behera, Pradnya D. Patil, Jung Min Song, Kathryn Demski, Pauline Funchain, Ann Yurco
Publikováno v:
Journal of Clinical Oncology. 38:61-61
61 Background: Immune checkpoint inhibitors (ICPis) have improved survival in melanoma patients, however their use is associated with 5-60% patients experiencing severe immune related adverse events (irAEs). Severe irAEs may affect survival benefit i
Publikováno v:
Journal of Clinical Oncology. 38:94-94
94 Background: VTE in cancer significantly contributes to morbidity and a worse overall prognosis. Little is known about the incidence of VTE in melanoma pts receiving IO. This study aims to assess the incidence of VTE in melanoma pts on IO, interrog
Autor:
Patricia Rayman, Paul G. Pavicic, Young Jun-Shim, C. Marcela Diaz-Montero, Keith R. McCrae, Shadi Swaidani, Cathy Charles, Joanna Roopkumar, Alok A. Khorana, Slato Paul, Pauline Funchain, Suman Kundu
Publikováno v:
Blood. 134:3648-3648
Introduction Immuno-oncology shows significant promise in the treatment of malignancy but is associated with a variety of immune-related adverse events. We previously reported that venous thromboembolism (VTE) occurred in over 20% of patients treated
Autor:
Jung-Min Song, Pauline Funchain, Muhammad Salman Faisal, Jessica Philpott, Roberto Simons-Linares, Ravi S. Shah, Joseph Sleiman
Publikováno v:
American Journal of Gastroenterology. 114:S58-S58
Autor:
Mohammad Alomari, Muhammad Talal Sarmini, Carlos Romero-Marrero, Mark J. Young, Laith Al Momani, Pauline Funchain, Suleiman Al Ashi, Fredy Nehme
Publikováno v:
American Journal of Gastroenterology. 114:S552-S552
Autor:
Joel Daniel Marcus, Pauline Funchain, Ann Yurco, Carolyn Stanek, David J. Savage, Jung Min Song, Rujul H Parikh, Benjamin Switzer
Publikováno v:
Journal of Clinical Oncology. 37:230-230
230 Background: Shared Medical Appointments (SMA) serve as a unique means of improving outcomes and patient satisfaction while reducing clinic wait times and healthcare costs. Early-stage melanoma survivors may benefit from a targeted SMA. This cohor
Publikováno v:
Journal of Investigative Dermatology. 139:B21